• No se han encontrado resultados

Altas dosis de. quimioterapia y trasplante de progenitores hematopoyéticos

N/A
N/A
Protected

Academic year: 2021

Share "Altas dosis de. quimioterapia y trasplante de progenitores hematopoyéticos"

Copied!
54
0
0

Texto completo

Loading

Referencias

Documento similar

De cette fa¸con, on fixe tous les param`etres de simulation aux valeurs d´etenues par le syst`eme d’implant cochl´eaire du patient, sauf un parmi eux, que l’on fait varier depuis

Tanto en calidad de vida, como estado de ánimo, apoyo social, autoestima, síntomas, y alteraciones del comportamiento, los pacientes adolescentes y adultos jóvenes

Keywords: iPSCs; induced pluripotent stem cells; clinics; clinical trial; drug screening; personalized medicine; regenerative medicine.. The Evolution of

Administration of the genetic combined vaccine was able to switch the immune response elicited against the LiPABP family after infection The immune response against the LiPABPs

Factors associated with death from infection after HSCT related to patient, disease, donor-type, stem cell source, year of transplant and center speci fic macro- or

No changes were observed in EC co-cultured with mock-treated B cells or stimulated B cells; only in the condition where EC were co-cultured with HIV-1 NL4-3 -treated B cells did

Nevertheless, irrespective of the influence of size and surface charge in the specific uptake of particles by dendritic cells, it seems clear that the most

Consiste en la administración de quimioterapia y/o radioterapia para preparar a la médula ósea para la recepción de los progenitores hematopoyéticos, así como para eliminar